ANDA for Atracurium Besylate Injection 1.0 mg/mL, 100 mL Flexible Container | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-1995-P-0325

ANDA for Atracurium Besylate Injection 1.0 mg/mL, 100 mL Flexible Container

Documents

Comments

Description

Docket Status: CLOSED

Comment Period OpensNov 13, 1995

Type	Title	Posted	Comments	Status
Other	Acknowledgment Letter from FDA DDM to Abbott Laboratories	Mar 30, 2017	--

INJECTION

ATRACUIUM BESYLATE

SUITABILITY

1.0MG/ML 100 ML SIZE

ANDA

CLOSED

CITIZEN PETITION

ABBOTT LABORATORIES

CDER